Dual Action Senna Stool Softener Capsule, Liquid Filled
Product Images NDC 83059-0091

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dual Action Senna Stool Softener (NDC 83059-0091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shield Pharmaceuticals Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Senna Label Back (Senna Label Back)

Drug Facts panel continuation from Dual Action Senna Stool Softener listing warnings, such as not to use mineral oil or for longer than 1 week unless directed by a doctor, and to stop use/ask a doctor if rectal bleeding occurs. Directions by age specify taking 1 to 4 softgel capsules once or twice daily. Other information includes storage instructions and active ingredients such as docusate sodium and sennosides. A 'Did you know?' section explains senna's natural origin, mechanism by stimulating colon muscles, and typical onset time within 6 to 12 hours, often taken at night.*

FDA Label Image

Senna Label Front (Senna Label Front)

Dual Action Senna + Stool Softener capsules with docusate sodium 50 mg and sennosides 8.6 mg liquid-filled softgels. The label states it contains natural ingredients from the senna plant, includes 120 softgels, and compares to Senokot-S active ingredients. Distributed by nexmed, made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.